Nurse Practitioner, Women’s Health · Ridgway, PA
NPI
1336760461
Since 2020
Specialty
Nurse Practitioner, Women’s Health
Code 363LW0102X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
123 Hospital Ave
Ridgway, PA, 15853
Phone (814) 371-1900
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,189
141 services
Medicare patients, 2024
93
Average age 67
Drug cost, 2024
$17K
177 prescriptions
Company payments, 2025
$359
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emily R Brazinski was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 55 times for 55 patients. In total Emily R Brazinski billed 141 services in 13 codes, and Medicare paid $4,189.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-24.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Facility | 55 | 55 | $21.89 | $1,204 |
| 99213 Office E&M - Established | Facility | 44 | 32 | $35.61 | $1,567 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Facility | 17 | 17 | $14.59 | $248 |
By year: 2022 $4,535 for 553 services; 2023 $3,178 for 114 services; 2024 $4,189 for 141 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emily R Brazinski prescribed most often to Medicare patients was Estradiol, with 27 prescriptions and refills. In total Emily R Brazinski wrote 177 Medicare prescriptions that cost $17K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 27 | 74 | 18 | $2,550 |
| Clobetasol Propionate Generic | 18 | 23 | 11 | $260 |
| Portia Levonorgestrel/Ethin.Estradiol | 14 | 14 | Under 11 | $240 |
Brand drugs: - claims; generic drugs: 154 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emily R Brazinski $359 ($359 in general payments such as food, travel and fees) from 3 companies. The largest payer was Astellas Pharma US Inc with $264.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.